Balimbingan, Verna .
HRN: 24-04-96 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/07/2023
CEFUROXIME 500MG (TAB)
11/07/2023
11/13/2023
PO
500
BID
CAP LR
Waiting Final Action
Indication: Empiric Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes